Results 151 to 160 of about 17,798 (188)

Lysosomal EGFR acts as a Rheb-GEF independent of its kinase activity to activate mTORC1. [PDF]

Cell Res
He X, Wang QX, Wei D, Lin Y, Zhang X, Wu Y, Qian X, Lin Z, Xiao B, Wu Q, Wang Z, Zhou F, Wei Z, Wang J, Gong R, Zhang R, Zhang Q, Ding K, Gao S, Kang T.   +19 more
europepmc   +1 more source

TKD XIII. Dönem Denetleme Kurulu Raporu

Türk Kütüphaneciliği, 2014
openaire   +1 more source

Efficacy of a teaching kitchen program for patients with type 2 diabetes in Japan: protocol for an open-label randomised controlled trial (TKD-J trial). [PDF]

BMJ Open
Baden MY, Kawamoto S, Kagisaki T, Kato S, Mitsushio K, Hara T, Ozawa H, Horii T, Ishibashi C, Hosokawa Y, Fujishima Y, Kozawa J, Nishizawa H, Muraki I, Furuya Y, Yonekura A, Yamashita T, Kawabe T, Massa J, McClure AC, Eisenberg DM, Hu FB, Shimomura I.   +22 more
europepmc   +1 more source

TKD characterization of low dimensional materials

, 2018
Bastos S. Fanta, Alice, Alekseeva, Svetlana, Langhammer, C., Viazmitinov, Dmitrii, Kasama, Takeshi, Semenova, Elizaveta, Burrows, Andrew   +6 more
openaire   +1 more source

Overexpression of Sterol Regulatory Element-binding Transcription Factor 2 is associated with an adverse prognosis in cytogenetically normal acute myeloid leukemia. [PDF]

Discov Oncol
Shan R, Wang J, Chen P, Wu T, Pang F, Yang R, Wei Y, Liu Q, Liu Y, Zhang R, Song M, Li X, Dong L, Feng C, Huang S.   +14 more
europepmc   +1 more source

TKD GENEL MERKEZ YÖNETİM KURULUNDAKİ DEĞİŞİKLİK

Türk Kütüphaneciliği, 1963
openaire   +1 more source

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML. [PDF]

Blood Adv
Russell N, Othman J, Cumming O, Thomas A, Tedjaseputra A, Potter N, Jovanovic J, Gilkes A, Batten L, Canham J, Hinson E, Runglall M, Aucken P, Kottaridis P, Cavenagh J, Arnold C, Freeman S, Dennis M, Knapper S, Dillon R.   +19 more
europepmc   +1 more source

Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors. [PDF]

Front Pharmacol
Zhang X, Peng Y, Tian Y, Chen S, Jia Y, Liu M, Zhang L.   +6 more
europepmc   +1 more source

A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non-Small Cell Lung Cancer. [PDF]

Arch Pharm (Weinheim)
Topalan E, Büyükgüngör A, Çiğdem M, Güra S, Sever B, Otsuka M, Fujita M, Demirci H, Ciftci H.   +8 more
europepmc   +1 more source

Improved radiation resistance in metals via adaptive martensitic transformation. [PDF]

Nat Commun
Zhang S, Dong YB, Sun YT, Liu Y, Sun LT, Zhao HW, Gao N, Wang ZB.   +7 more
europepmc   +1 more source